If there must be a poster child for the 6-year cyclical bull market, it is likely the biotech sector. At least that is certainly true…
Tagged Biotech
Another Bullish Setup For Biotech?
While the post-2009 cyclical bull market has yet to run its course, there is a clear leader in the clubhouse in the race for poster…
Biotech Sector: Support Levels To Watch No sector has exemplified these past few years of the cyclical bull market as much as biotechnology stocks. Likewise,…
Signs of Froth in the Biotech Sector
There is a fervent debate in some financial circles regarding the existence – or non-existence – of a biotech bubble. It is a challenging, and…
Biotech ETF IBB: Cup-&-Handle Breakout Enough said. ________ More from Dana Lyons, JLFMI and My401kPro.
Bull Flag Signaling 1 More Chance To Buy This Biotech ETF? Biotech stocks have alternated between hero and villain in 2014 (FYI, we have been…
Margin Debt Cycle: Not Dead Yet?
The NYSE released their June margin debt update yesterday and it was a doozy. Margin debt jumped nearly 6% to just 0.3% shy of the…
Sector Spotlight: iShares Nasdaq Biotech $IBB-Preliminary Support @ 244-245
We’ve discussed biotechs a lot lately both here and in our newsletters. They remain a big focus for us as a possible canary, considering their…
StOTD-6/11/14: Biotechs & Semis are YTD Leaders @ +15%; 3 Months Ago Semis Trailed Bio by 15%
Two of the YTD performance leaders are the Biotechs ($BTK) and Semiconductors ($SOX), both up roughly 15%. However, the paths to that 15% return could…
UPDATE: Biotech Index, ETF’s reach 61.8% Fibonacci Retracement of Feb-Apr Decline
On April 9, we pointed out a key Fibonacci Retracement cluster of support on the S&P SPDR Biotech ETF, $XBI (also generally corresponding with similar…